EMPHYSEMA
Clinical trials for EMPHYSEMA explained in plain language.
Never miss a new study
Get alerted when new EMPHYSEMA trials appear
Sign up with your email to follow new studies for EMPHYSEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a higher dose slow lung damage in Alpha-1 patients?
Disease control Not yet recruitingThis study tests whether higher doses of the drug Respreeza/Zemaira can slow lung damage better than the standard dose in adults with emphysema caused by Alpha-1 antitrypsin deficiency. About 270 participants will receive weekly IV infusions for 3 years. The goal is to find the o…
Matched conditions: EMPHYSEMA
Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New scan could boost success of lung valve treatment for emphysema
Disease control Not yet recruitingThis study tests whether a special scan (VQDI) can help doctors pick the best lung area to place tiny valves for severe emphysema. About 285 participants will be randomly assigned to have valve placement guided by either the new scan or the usual CT scan. The goal is to see if th…
Matched conditions: EMPHYSEMA
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Gene mutation linked to unexplained emphysema?
Knowledge-focused Not yet recruitingThis study aims to find out how often people with FLNA gene mutations develop emphysema, a type of lung disease. Researchers will use chest CT scans, blood tests, and lung function tests in 70 participants. The goal is to confirm if FLNA changes are a cause of unexplained emphyse…
Matched conditions: EMPHYSEMA
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC